In Oregon, the PDAB meeting concluded the 2025 drug affordability review, with the board identifying Cosentyx, Trulicity, and Vraylar as posing affordability challenges and adding Lantus Solostar to meet statutory requirements
Multiple factors influence the speed and magnitude of response to GLP-1 medications
Common claims involve gastroparesis and gallbladder issues
Tercero, retrasa el vaciamiento gstrico, lo que prolonga la sensacin de saciedad y reduce el apetito
The bottom line There are lots of positive health benefits from using a GLP-1 to eat less and lose weight, but there are also a few challenges, especially losing bone density and muscle mass
In contrast to generic medicines which are exact copies of chemically synthesised branded drugs, biosimilars closely resemble the structure and function of their reference product and are produced in modified living organisms like yeast and bacteria